Table 16.
No. | ID | Description | Significant | Annotated | p-value | q-value |
---|---|---|---|---|---|---|
1 | ko00190 | Oxidative phosphorylation | 74/331 | 108/5400 | 1.14E-66 | 2.01E-64 |
2 | ko04260 | Cardiac muscle contraction | 27/331 | 54/5400 | 2.79E-19 | 2.46E-17 |
3 | ko00020 | Citrate cycle (TCA cycle) | 16/331 | 24/5400 | 1.31E-14 | 7.70E-13 |
4 | ko01200* | Carbon metabolism | 28/331 | 94/5400 | 5.94E-13 | 2.61E-11 |
5 | ko00640* | Propanoate metabolism | 9/331 | 21/5400 | 1.67E-06 | 5.88E-05 |
6 | ko00620 | Pyruvate metabolism | 10/331 | 28/5400 | 3.18E-06 | 9.32E-05 |
7 | ko01210 | 2-Oxocarboxylic acid metabolism | 6/331 | 13/5400 | 6.02E-05 | 0.002 |
8 | ko00010 | Glycolysis / Gluconeogenesis | 11/331 | 48/5400 | 0.000 | 0.002 |
9 | ko02020 | Two-component system | 5/331 | 10/5400 | 0.000 | 0.003 |
10 | ko00280* | Valine, leucine and isoleucine degradation | 9/331 | 35/5400 | 0.000 | 0.003 |
11 | ko00720 | Carbon fixation pathways in prokaryotes | 5/331 | 11/5400 | 0.000 | 0.005 |
12 | ko04020* | Calcium signaling pathway | 16/331 | 105/5400 | 0.001 | 0.008 |
13 | ko04922* | Glucagon signaling pathway | 11/331 | 59/5400 | 0.001 | 0.010 |
14 | ko03010* | Ribosome | 18/331 | 133/5400 | 0.001 | 0.014 |
15 | ko04261 | Adrenergic signaling in cardiomyocytes | 14/331 | 92/5400 | 0.001 | 0.015 |
16 | ko00650* | Butanoate metabolism | 6/331 | 22/5400 | 0.002 | 0.017 |
17 | ko00710 | Carbon fixation in photosynthetic organisms | 6/331 | 22/5400 | 0.002 | 0.017 |
18 | ko00071* | Fatty acid degradation | 7/331 | 30/5400 | 0.002 | 0.018 |
19 | ko04022* | cGMP - PKG signaling pathway | 15/331 | 108/5400 | 0.002 | 0.021 |
20 | ko01230* | Biosynthesis of amino acids | 10/331 | 63/5400 | 0.005 | 0.040 |
Note: * also significantly expressed in other organs. Sorted by q-value.